DEALS
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeBankruptcy, Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia, Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
-
Zhong Lun Assists Medprin to List on ChiNext
Zhong Lun acted as legal counsel for the offering. Having provided legal services for the client’s previous rounds of financing, regulation of its employee stock ownership, and the entire process of its listing.
2021-08-06
-
- 2021-08-06
-
Zhong Lun Supports HCpect in its Listing of Convertible Bonds
Zhong Lun served as legal counsel for the listing.
-
- 2021-07-30
-
Zhong Lun Assists the Successful Renewal of the Largest Scale CMBS Product in History Backed by a Single-purpose Shopping Center
Zhong Lun provided the Special Scheme with a variety of legal services, including designing product proposal, conducting legal due diligence on underlying assets, drafting and revising transaction documents, and issuing legal opinions.
-
- 2021-07-27
-
Zhong Lun Advises Microvast in $3 Billion SPAC Deal
Zhong Lun as the legal counsel of Microvast, was responsible for (i) conducting legal due diligence on PRC subsidiaries of Microvast, (ii) structuring both onshore and offshore institutional investors’ investments in Microvast, (iii) reviewing and drafting relevant transaction documents, and (iv) coordinating with onshore and offshore professional agencies.
-
- 2021-07-27
-
Zhonglun Law Firm advised Immorna on the formation of a joint venture with Junshi Biosciences to jointly develop self-replicating and conventional mRNA innovative drugs and vaccines
Zhong Lun Law Firm acted as the external legal advisor for Immorna and was comprehensively involved in the negotiation and signing of the Project, as well as assisting the parties in reviewing, revising and finalizing the relevant transaction documents, including the Joint Venture Contract, the Articles of Association and the Technology Licensing Agreement.